Zhen-yi Wang
From Wikipedia, the free encyclopedia
Zhen-yi Wang is a Chinese pathophysiologist and the Professor of Medicine and Pathophysiology at the Shanghai Jiao Tong University (SSMU) in Shanghai, China. A full professor at Shanghai Second Medical University before its amalgamation, from 1987 to 1996 he was Director of the Hematology Institute at Rai-Jin Hospital in Shanghai. His research has led to the improved survival of patients with acute promyelocytic leukemia (APML).
Dr. Wang is the author of more than 300 scientific papers and books and is the recipient of numerous awards including the Kettering Prize for Cytodifferentiation Therapy, the Prix mondial Cino Del Duca for science, and the Charles Rodolphe Brupbacher Prize given for his "extraordinary contributions to basic oncological research." He received an honorary doctor of science degree from Columbia University in 2001 and was honored for his work as the 2003 Ham-Wasserman Lecturer, American Society of Hematology.
Dr. Wang is a member of the Chinese Society of Pathophysiology, French Academy of Sciences, International Society of Fibrinolysis and Chinese Society of Engineering.